Rapid development of seizures and PRES in a COVID-19 patient

Neurological dysfunction has been noted in up to 36% of patients hospitalized with COVID-19, and a variety of mechanisms of neurological injury are possible. Here we report the rapid development of PRES and acute seizures in a patient with COVID-19 infection and sickle cell disease. The combination...

Descripción completa

Detalles Bibliográficos
Autores principales: Santos de Lima, Fabiane, Klein, Sara, El Ammar, Faten, Wu, Shasha, Rose, Sandra, Tao, James X., Issa, Naoum P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931684/
https://www.ncbi.nlm.nih.gov/pubmed/33688630
http://dx.doi.org/10.1016/j.ebr.2021.100436
_version_ 1783660342740516864
author Santos de Lima, Fabiane
Klein, Sara
El Ammar, Faten
Wu, Shasha
Rose, Sandra
Tao, James X.
Issa, Naoum P.
author_facet Santos de Lima, Fabiane
Klein, Sara
El Ammar, Faten
Wu, Shasha
Rose, Sandra
Tao, James X.
Issa, Naoum P.
author_sort Santos de Lima, Fabiane
collection PubMed
description Neurological dysfunction has been noted in up to 36% of patients hospitalized with COVID-19, and a variety of mechanisms of neurological injury are possible. Here we report the rapid development of PRES and acute seizures in a patient with COVID-19 infection and sickle cell disease. The combination of COVID and sickle cell disease may raise the risk of PRES and could contribute to the higher mortality rate of COVID in patients with sickle cell disease.
format Online
Article
Text
id pubmed-7931684
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-79316842021-03-05 Rapid development of seizures and PRES in a COVID-19 patient Santos de Lima, Fabiane Klein, Sara El Ammar, Faten Wu, Shasha Rose, Sandra Tao, James X. Issa, Naoum P. Epilepsy Behav Rep Case Report Neurological dysfunction has been noted in up to 36% of patients hospitalized with COVID-19, and a variety of mechanisms of neurological injury are possible. Here we report the rapid development of PRES and acute seizures in a patient with COVID-19 infection and sickle cell disease. The combination of COVID and sickle cell disease may raise the risk of PRES and could contribute to the higher mortality rate of COVID in patients with sickle cell disease. Elsevier 2021-03-04 /pmc/articles/PMC7931684/ /pubmed/33688630 http://dx.doi.org/10.1016/j.ebr.2021.100436 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Santos de Lima, Fabiane
Klein, Sara
El Ammar, Faten
Wu, Shasha
Rose, Sandra
Tao, James X.
Issa, Naoum P.
Rapid development of seizures and PRES in a COVID-19 patient
title Rapid development of seizures and PRES in a COVID-19 patient
title_full Rapid development of seizures and PRES in a COVID-19 patient
title_fullStr Rapid development of seizures and PRES in a COVID-19 patient
title_full_unstemmed Rapid development of seizures and PRES in a COVID-19 patient
title_short Rapid development of seizures and PRES in a COVID-19 patient
title_sort rapid development of seizures and pres in a covid-19 patient
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7931684/
https://www.ncbi.nlm.nih.gov/pubmed/33688630
http://dx.doi.org/10.1016/j.ebr.2021.100436
work_keys_str_mv AT santosdelimafabiane rapiddevelopmentofseizuresandpresinacovid19patient
AT kleinsara rapiddevelopmentofseizuresandpresinacovid19patient
AT elammarfaten rapiddevelopmentofseizuresandpresinacovid19patient
AT wushasha rapiddevelopmentofseizuresandpresinacovid19patient
AT rosesandra rapiddevelopmentofseizuresandpresinacovid19patient
AT taojamesx rapiddevelopmentofseizuresandpresinacovid19patient
AT issanaoump rapiddevelopmentofseizuresandpresinacovid19patient

Ejemplares similares